Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

1.

Correcting for cell-type heterogeneity in epigenome-wide association studies: revisiting previous analyses.

Nat. Methods.
Zheng SC, Beck S, Jaffe AE, Koestler DC, Hansen KD, Houseman AE, Irizarry RA, Teschendorff AE.
| Feb 28, 2017
2.

Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast cancer cells.

Proc. Natl. Acad. Sci. U.S.A.
Tavera-Mendoza LE, Westerling T, Libby E, Marusyk A, Cato L, Cassani R, Cameron LA, Ficarro SB, Marto JA, Klawitter J, Brown M.
| Feb 27, 2017
3.

ENL links histone acetylation to oncogenic gene expression in acute myeloid leukaemia.

Nature.
Wan L, Wen H, Li Y, Lyu J, Xi Y, Hoshii T, Joseph JK, Wang X, Loh YE, Erb MA, Souza AL, Bradner JE, Shen L, Li W, Li H, Allis CD, Armstrong SA, Shi X.
| Mar 01, 2017
4.

Transcription control by the ENL YEATS domain in acute leukaemia.

Nature.
Erb MA, Scott TG, Li BE, Xie H, Paulk J, Seo HS, Souza A, Roberts JM, Dastjerdi S, Buckley DL, Sanjana NE, Shalem O, Nabet B, Zeid R, Offei-Addo NK, Dhe-Paganon S, Zhang F, Orkin SH, Winter GE, Bradner JE.
| Mar 01, 2017
5.

TIRR regulates 53BP1 by masking its histone methyl-lysine binding function.

Nature.
Drané P, Brault ME, Cui G, Meghani K, Chaubey S, Detappe A, Parnandi N, He Y, Zheng XF, Botuyan MV, Kalousi A, Yewdell WT, Münch C, Harper JW, Chaudhuri J, Soutoglou E, Mer G, Chowdhury D.
| Feb 27, 2017
6.

Doubling Down on Mutant RAS Can MEK or Break Leukemia.

Cell.
Tothova Z, Ebert BL.
| Feb 23, 2017
7.

Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction.

Immunity.
Abelin JG, Keskin DB, Sarkizova S, Hartigan CR, Zhang W, Sidney J, Stevens J, Lane W, Zhang GL, Eisenhaure TM, Clauser KR, Hacohen N, Rooney MS, Carr SA, Wu CJ.
| Feb 21, 2017
8.

Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma.

Immunity.
George S, Miao D, Demetri GD, Adeegbe D, Rodig SJ, Shukla S, Lipschitz M, Amin-Mansour A, Raut CP, Carter SL, Hammerman P, Freeman GJ, Wu CJ, Ott PA, Wong KK, Van Allen EM.
| Feb 21, 2017
9.

Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism.

Nature.
Pan Y, Tian T, Park CO, Lofftus SY, Mei S, Liu X, Luo C, O'Malley JT, Gehad A, Teague JE, Divito SJ, Fuhlbrigge R, Puigserver P, Krueger JG, Hotamisligil GS, Clark RA, Kupper TS.
| Feb 20, 2017
10.

Variant-aware saturating mutagenesis using multiple Cas9 nucleases identifies regulatory elements at trait-associated loci.

Nat. Genet.
Canver MC, Lessard S, Pinello L, Wu Y, Ilboudo Y, Stern EN, Needleman AJ, Galactéros F, Brugnara C, Kutlar A, McKenzie C, Reid M, Chen DD, Das PP, A Cole M, Zeng J, Kurita R, Nakamura Y, Yuan GC, Lettre G, Bauer DE, Orkin SH.
| Feb 20, 2017
11.

HSP90 Shapes the Consequences of Human Genetic Variation.

Cell.
Karras GI, Yi S, Sahni N, Fischer M, Xie J, Vidal M, D'Andrea AD, Whitesell L, Lindquist S.
| Feb 23, 2017
12.

11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial.

Lancet.
Cameron D, Piccart-Gebhart MJ, Gelber RD, Procter M, Goldhirsch A, de Azambuja E, Castro G, Untch M, Smith I, Gianni L, Baselga J, Al-Sakaff N, Lauer S, McFadden E, Leyland-Jones B, Bell R, Dowsett M, Jackisch C.
| Feb 16, 2017
13.

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.

N. Engl. J. Med.
Bellmunt J, de Wit R, Vaughn DJ, Fradet Y, Lee JL, Fong L, Vogelzang NJ, Climent MA, Petrylak DP, Choueiri TK, Necchi A, Gerritsen W, Gurney H, Quinn DI, Culine S, Sternberg CN, Mai Y, Poehlein CH, Perini RF, Bajorin DF.
| Feb 17, 2017
14.

Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells.

Nature.
Compagno M, Wang Q, Pighi C, Cheong TC, Meng FL, Poggio T, Yeap LS, Karaca E, Blasco RB, Langellotto F, Ambrogio C, Voena C, Wiestner A, Kasar SN, Brown JR, Sun J, Wu CJ, Gostissa M, Alt FW, Chiarle R.
| Feb 23, 2017
15.

G1 cyclins link proliferation, pluripotency and differentiation of embryonic stem cells.

Nat. Cell Biol.
Liu L, Michowski W, Inuzuka H, Shimizu K, Nihira NT, Chick JM, Li N, Geng Y, Meng AY, Ordureau A, Kołodziejczyk A, Ligon KL, Bronson RT, Polyak K, Harper JW, Gygi SP, Wei W, Sicinski P.
| Feb 13, 2017
16.

The Ndc80 complex bridges two Dam1 complex rings.

Elife.
Kim JO, Zelter A, Umbreit NT, Bollozos A, Riffle M, Johnson R, MacCoss MJ, Asbury CL, Davis TN.
| Feb 13, 2017
17.

Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer.

Elife.
Li J, Alyamani M, Zhang A, Chang KH, Berk M, Li Z, Zhu Z, Petro M, Magi-Galluzzi C, Taplin ME, Garcia JA, Courtney K, Klein EA, Sharifi N.
| Feb 13, 2017
18.

Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer.

Cell.
Cubillos-Ruiz JR, Bettigole SE, Glimcher LH.
| Feb 09, 2017
19.

Understanding the Intersections between Metabolism and Cancer Biology.

Cell.
Vander Heiden MG, DeBerardinis RJ.
| Feb 09, 2017
20.

Applications of Immunogenomics to Cancer.

Cell.
Liu XS, Mardis ER.
| Feb 09, 2017